BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 29653556)

  • 21. Fifty C-terminal amino acid residues are necessary for the chaperone activity of DFF45 but not for the inhibition of DFF40.
    Park HH
    BMB Rep; 2009 Nov; 42(11):713-8. PubMed ID: 19944011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis.
    Rauh-Hain JA; Vargas RJ; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
    Am J Clin Oncol; 2016 Feb; 39(1):43-8. PubMed ID: 24390270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.
    Van Gool IC; Stelloo E; Nout RA; Nijman HW; Edmondson RJ; Church DN; MacKay HJ; Leary A; Powell ME; Mileshkin L; Creutzberg CL; Smit VT; Bosse T
    Mod Pathol; 2016 Feb; 29(2):174-81. PubMed ID: 26743472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers.
    Moroney MR; Davies KD; Wilberger AC; Sheeder J; Post MD; Berning AA; Fisher C; Lefkowits C; Guntupalli SR; Behbakht K; Corr BR
    Gynecol Oncol; 2019 Jun; 153(3):517-520. PubMed ID: 30910249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic factors in diagnosed endometrial cancers determining the type of radical surgery].
    Ivanov S; Tomov S
    Akush Ginekol (Sofiia); 2009; 48(3):14-9. PubMed ID: 20198758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between mutant p53 gene, DNA contents and conventional clinicopathological prognostic variables in cases with endometrial carcinoma.
    Osmanağaoğlu MA; Kadioğlu S; Osmanağaoğlu S; Bozkaya H; Reis A; Tekelioğlu Y
    Eur J Gynaecol Oncol; 2005; 26(1):64-70. PubMed ID: 15755004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation.
    Wolf BB; Schuler M; Echeverri F; Green DR
    J Biol Chem; 1999 Oct; 274(43):30651-6. PubMed ID: 10521451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of DNA fragmentation factor and poly(ADP-ribose) polymerase-1 in sensitization of fibroblasts to tumor necrosis factor-induced apoptosis.
    Boulares AH; Zoltoski AJ; Sherif ZA; Yakovlev A; Smulson ME
    Biochem Biophys Res Commun; 2002 Jan; 290(2):796-801. PubMed ID: 11785971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis.
    Liu X; Li P; Widlak P; Zou H; Luo X; Garrard WT; Wang X
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8461-6. PubMed ID: 9671700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of Wnt7a is associated with tumor progression and unfavorable prognosis in endometrial cancer.
    Liu Y; Meng F; Xu Y; Yang S; Xiao M; Chen X; Lou G
    Int J Gynecol Cancer; 2013 Feb; 23(2):304-11. PubMed ID: 23321718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
    Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
    Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation spectrum of POLE and POLD1 mutations in South East Asian women presenting with grade 3 endometrioid endometrial carcinomas.
    Wong A; Kuick CH; Wong WL; Tham JM; Mansor S; Loh E; Jain S; Vikas NN; Tan SH; Chan SH; Li ST; Chew SH; Hong W; Ngeow J
    Gynecol Oncol; 2016 Apr; 141(1):113-20. PubMed ID: 26748215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
    Zhang X; Dong Y; Ti H; Zhao J; Wang Y; Li T; Zhang B
    Hum Pathol; 2013 Nov; 44(11):2571-80. PubMed ID: 24071015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mismatch repair status in high-grade endometrial carcinomas of endometrioid and non-endometrioid type.
    Doulgeraki T; Vagios S; Kavoura E; Yiannou P; Messini I; Nonni A; Papadimitriou C; Vlachos A; Pavlakis K
    J BUON; 2019; 24(5):2020-2027. PubMed ID: 31786870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review.
    Esselen KM; Boruta DM; del Carmen M; Schorge JO; Goodman A; Growdon WB
    Int J Gynecol Cancer; 2011 Aug; 21(6):1078-83. PubMed ID: 21633304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of regulatory and catalytic domains in the apoptosis nuclease DFF40/CAD.
    Inohara N; Koseki T; Chen S; Benedict MA; Núñez G
    J Biol Chem; 1999 Jan; 274(1):270-4. PubMed ID: 9867840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women.
    He D; Wang H; Dong Y; Zhang Y; Zhao J; Lv C; Zheng X; Li D; Li T
    Gynecol Oncol; 2020 Oct; 159(1):36-42. PubMed ID: 32800323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.